GB0908317D0 - Pharmaceutical compounds and compositions - Google Patents

Pharmaceutical compounds and compositions

Info

Publication number
GB0908317D0
GB0908317D0 GB0908317A GB0908317A GB0908317D0 GB 0908317 D0 GB0908317 D0 GB 0908317D0 GB 0908317 A GB0908317 A GB 0908317A GB 0908317 A GB0908317 A GB 0908317A GB 0908317 D0 GB0908317 D0 GB 0908317D0
Authority
GB
United Kingdom
Prior art keywords
compositions
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0908317A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GB0908317A priority Critical patent/GB0908317D0/en
Publication of GB0908317D0 publication Critical patent/GB0908317D0/en
Priority to PCT/GB2010/050767 priority patent/WO2010131030A1/en
Ceased legal-status Critical Current

Links

GB0908317A 2009-05-14 2009-05-14 Pharmaceutical compounds and compositions Ceased GB0908317D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0908317A GB0908317D0 (en) 2009-05-14 2009-05-14 Pharmaceutical compounds and compositions
PCT/GB2010/050767 WO2010131030A1 (en) 2009-05-14 2010-05-11 Pyridylurea derivatives and their therapeutic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0908317A GB0908317D0 (en) 2009-05-14 2009-05-14 Pharmaceutical compounds and compositions

Publications (1)

Publication Number Publication Date
GB0908317D0 true GB0908317D0 (en) 2009-06-24

Family

ID=40834001

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0908317A Ceased GB0908317D0 (en) 2009-05-14 2009-05-14 Pharmaceutical compounds and compositions

Country Status (2)

Country Link
GB (1) GB0908317D0 (en)
WO (1) WO2010131030A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107286083A (en) * 2017-06-16 2017-10-24 康化（上海）新药研发有限公司 A kind of synthetic method of the pyridine carboxaldehyde of 2 chlorine, 6 bromine 3
CN107674042B (en) * 2017-09-28 2020-09-25 河南科技大学 Ultrasonic solvent-free synthesis method of thiadiazole compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147080A (en) * 1996-12-18 2000-11-14 Vertex Pharmaceuticals Incorporated Inhibitors of p38
MY132496A (en) * 1998-05-11 2007-10-31 Vertex Pharma Inhibitors of p38
AR023659A1 (en) * 1998-09-18 2002-09-04 Vertex Pharma AN INHIBITOR COMPOUND OF P38, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND THE USE OF SUCH COMPOSITION IN THE TREATMENT AND PREVENTION OF PATHOLOGICAL STATES
WO2001070695A1 (en) * 2000-03-22 2001-09-27 Vertex Pharmaceuticals Incorporated Pyridine derivatives as inhibitors of p38
AU8323701A (en) * 2000-08-11 2002-02-25 John Cochran Inhibitors of p38
JP4675318B2 (en) * 2003-02-10 2011-04-20 バーテックス ファーマシューティカルズ インコーポレイテッド Process for the preparation of N-heteroaryl-N-aryl-amines by reacting N-arylcarbamates with halo-heteroaryls and similar processes
MX2008011490A (en) * 2006-03-07 2009-01-07 Vertex Pharma Use of vx-702 for treating rheumatoid arthritis.

Also Published As

Publication number Publication date
WO2010131030A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
IL215451A0 (en) Pharmaceutical composition
IL243015B (en) Multicyclic compounds and pharmaceutical compositions comprising them
SG2014012405A (en) Pharmaceutical compositions
GB0814695D0 (en) Pharmaceutical compositions
SG10201403696UA (en) Therapeutic compounds and compositions
IL217912A (en) 5-amino-1- benzimidazole-pyrazole derivatives and pharmaceutical compositions comprising them
PL2323623T3 (en) Pharmaceutical compositions
EP2379077A4 (en) Pharmaceutical composition
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
IL247086A0 (en) Nitrogen-containing compounds and pharmaceutical compositions
ZA201200079B (en) Pharmaceutical compositions and solid forms
IL206487A0 (en) Pharmaceutical compositions
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL219018A0 (en) Pharmaceutical compositions
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0919650D0 (en) Pharmaceutical composition
GB0800659D0 (en) Pharmaceutical Compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions
GB0910225D0 (en) Pharmaceutical compositions
HU0900010D0 (en) Improved pharmaceutical composition
GB0908970D0 (en) Local pharmaceutical compositions
GB0802024D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)